TrialTransplantation and cellular therapy2026
Financial Toxicity in a Phase I/II Trial of LV20.19 CAR-T Cell for B-cell Malignancies: A Longitudinal, Qualitative Study.
Elizabeth Aughey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.